Zdrowie i gospodarka · 16/02/2018

FDA Releases Guidance for Industry on Duchenne Muscular Dystrophy Treatment Development

The Food and Drug Administration (FDA) has released a guidance document to help pharmaceutical companies develop treatments for Duchenne Muscular Dystrophy (DMD) and related conditions, following the completion of a draft guidance published in June 2015.